OSYRIS
GLOW

Aesthetics

GLOW

$89.99

GLOW is a proprietary multi-peptide research blend composed of GHK-Cu (50MG), BPC-157 (10MG), and TB-500 (10MG), formulated for synergistic in vitro and in vivo study of cellular signaling, tissue regeneration, angiogenesis, and peptide-receptor interactions. This product is supplied as a lyophilized powder and is intended strictly for research purposes only.

Quantity
Standard research vial
Purity
See COA

Standard $9.99 | Expedited $12.99 | Free standard over $200

Download Certificate of Analysis
Research On This Compound

GLOW vs KLOW — Choosing the Right Stack

7 min read · COMPARISON · Comparison
RESEARCH

GHK-Cu — How a Three-Amino-Acid Copper Complex Modulates 4,000 Genes

Comprehensive GHK-Cu copper peptide research overview. Gene expression, collagen synthesis, wound healing, antioxidant. PubMed citations.
RESEARCH

BPC-157 vs TB-500 — Two Paths to Tissue Repair

BPC-157 vs TB-500 compared: mechanisms, research applications, key studies. Growth factors vs actin dynamics. Which compound for which protocol?
CATEGORY GUIDE

Recovery Peptides — Research Mechanisms and Compound Guide

Complete guide to recovery and tissue repair peptides. BPC-157, TB500, blends compared. Mechanisms, research applications, how to choose.
CATEGORY GUIDE

Aesthetics Peptides — Skin Biology, Collagen, and Pigmentation Research

Complete guide to aesthetics and skin biology research compounds. Collagen synthesis, melanogenesis, gene expression, antioxidant defense.
Practical Guides
How to Read a Certificate of Analysis Peptide Storage and Handling Understanding Peptide Purity Testing

Research overview

GLOW Peptide Blend: Research Overview

This blend combines three distinct peptides with well-characterized research profiles:

  • GHK-Cu (Copper Tripeptide): A naturally occurring copper-binding peptide involved in gene expression, tissue remodeling, and anti-inflammatory signaling
  • BPC-157: A synthetic peptide fragment derived from body protection compound, studied for its influence on angiogenesis, cell migration, and cytokine activity
  • TB-500 (Thymosin Beta-4 Fragment): A synthetic version of a naturally occurring actin-sequestering peptide, associated with cell migration, wound modeling, and vascular modulation
The specific ratio of this formulation (GHK-Cu 50%, BPC-157 5%, TB-500 10%) allows researchers to examine additive or synergistic effects across multiple biochemical pathways relevant to cell signaling and structural integrity.

1. GHK-Cu: Gene Expression and Tissue Remodeling

GHK-Cu has been shown to modulate the expression of hundreds of genes related to:
  • Tissue repair, collagen synthesis, and extracellular matrix remodeling
  • Anti-inflammatory signaling through inhibition of TNF-α and IL-6 expression [1]
  • Copper ion delivery into cells, promoting antioxidant enzyme function and cellular respiration [2]
Studies have used gene array profiling and RNA sequencing to document the changes GHK-Cu induces in fibroblasts, keratinocytes, and endothelial cells.

2. BPC-157: Angiogenesis and Cytokine Modulation

BPC-157 is widely used in models studying angiogenesis and vascular repair:
  • Promotes vascular endothelial growth factor (VEGF) expression and endothelial cell proliferation [3]
  • Modulates cytokine levels, reducing IL-1β, IL-6, and TNF-α in inflamed tissue models
  • Demonstrated ability to support tendon fibroblast migration in rat explant studies [4]
Its stability in gastric juice and plasma allows for extended study windows in gastrointestinal and musculoskeletal research models.

3. TB-500: Cell Migration and Actin Regulation

TB-500 (the synthetic form of Thymosin Beta-4) is studied for its ability to:
  • Regulate actin polymerization, enhancing cell motility and wound closure [5]
  • Promote angiogenesis through upregulation of VEGF and other pro-vascular signals
  • Reduce oxidative stress and tissue fibrosis in preclinical cardiac and dermal models [6]
Researchers frequently use TB-500 to model tissue regeneration, particularly in cardiovascular, muscular, and epithelial contexts.

Synergistic Applications of the GLOW Blend

The combination of these three peptides in GLOW supports advanced studies in:
  • Wound healing and epithelial regeneration
  • Angiogenic and anti-inflammatory signaling
  • Fibroblast migration and collagen matrix production
  • Neurovascular remodeling and tissue oxygenation
Co-administration in this ratio enables researchers to evaluate multi-pathway peptide crosstalk and downstream transcriptional effects using in vitro and animal model systems.

Related products